{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_181812.3:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_181812.3",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant"
        },
        {
          "HGVS": "NM_181812.3:c.4321C>T",
          "cDNA Change": {
            "transcript": "NM_181812.3",
            "ref": "C",
            "alt": "T",
            "position": "4321"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005301"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Experiments conducted using HEK293 cells overexpressing LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181812.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity and phosphorylation of downstream targets (e.g., Rab10) observed in G2019S-expressing cells."
        },
        {
          "Variant": "NM_181812.3:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced autophagic flux and impaired mitochondrial function in R1441C-expressing cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test and ANOVA used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels ≤ 20% above wild-type baseline.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels ≥ 50% above wild-type baseline for G2019S; autophagic flux ≤ 30% of wild-type for R1441C.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Immunofluorescence analysis performed on HEK293 cells expressing LRRK2 variants."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_181812.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased cytoplasmic aggregation of LRRK2-G2019S observed compared to wild-type."
        },
        {
          "Variant": "NM_181812.3:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced mitochondrial localization of LRRK2-R1441C observed."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition imaged in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Chi-square test used for qualitative data."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant aggregation or localization changes compared to wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation ≥ 40% of cells or localization changes ≥ 50% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "In vitro kinase activity assays performed on purified LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_181812.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2-G2019S showed 2–3 fold increased kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_181812.3:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "LRRK2-R1441C showed 40–50% reduced kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition tested in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Kinase-inactive LRRK2 mutant used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Z-test used for kinase activity comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 20% of wild-type range.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity ≥ 50% above or below wild-type range.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}